跳至主要内容
临床试验/NL-OMON40814
NL-OMON40814已完成不适用

The role of inflammation in myocardial infarction in young patients without risk factors: * the unhappy few* - A pilot study - - The Unhappy Few

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Twenty patients aged between 18 and 50 year, who present with an acute ST-elevation myocardial infarction eligible for primary percutaneous coronary intervention. ;Family members:
  • Forty of their first degree healthy family members of the patients presenting with the acute myocardial infarction (two family members per patient).;Controls:
  • 20 healthy controls aged 18 years or above. Controls will be matched with the cases for age, gender and cardiovascular risk factors.

排除标准

  • - If the index patient (suffering from the acute myocardial infarction) has one or more of the following factors present:
  • o Age below 18 years
  • o Diagnosis of vascular disease (e.g. previous myocardial infarction, CVA, etc)
  • o Use of statins, anti-inflammatory agents or thrombocyte aggregation inhibitors (these drugs modulate epigenetic changes in in vitro studies)
  • o Auto-immune diseases (e.g. rheumatoid arthritis)
  • o Coagulation disorder
  • o No living first degree family members aged 18 years or above
  • o Presence of two or more of the following risk factors:
  • § Hypertension
  • § Hypercholesterolemia
  • § Diabetes mellitus
  • § Active smoking or an active smoking history within the last 10 years;Family members:
  • - If the first degree relative (i.e. the participant) has one or more of the following factors present:
  • o Age below 18 years
  • o History of vascular disease (e.g. previous myocardial infarction, CVA, etc)
  • o Use of statins, anti-inflammatory agents or thrombocyte aggregation inhibitors (these drugs modulate epigenetic changes in in vitro studies)
  • o Signs or symptoms of a current infection (fever, chills)
  • o Auto-immune diseases (e.g. rheumatoid arthritis)
  • o Coagulation disorder
  • - If the control has one or more of the following factors present:
  • o Age below 18 years
  • o History of vascular disease (e.g. previous myocardial infarction, CVA, etc)
  • o A first degree family member with vascular disease (e.g. previous myocardial infarction, CVA, etc)
  • o Family relationship with the cases
  • o Use of statins, anti-inflammatory agents or thrombocyte aggregation inhibitors (these drugs modulate epigenetic changes in in vitro studies)
  • o Signs or symptoms of a current infection (fever, chills)
  • o Auto-immune diseases (e.g. rheumatoid arthritis)
  • o Coagulation disorder

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验